Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose

Clinical trial NCT01171989 · COMPLETED

Trial details

NCT number: NCT01171989
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tetanus Diphtheria Haemophilus Influenzae Type b Hepatitis B Poliomyelitis Acellular Pertussis Diphtheria-Tetanus-aPertussis-Hepatitis B-Poliomyelitis-Haemophilus Influenzae Type b-Neisseria Meni

Start date: 2010-08-18
Primary completion: 2010-12-03
Enrollment: 391

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.